Victory Capital Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$638K Buy
45,616
+3,989
+10% +$55.8K ﹤0.01% 2006
2025
Q1
$566K Buy
41,627
+3,119
+8% +$42.4K ﹤0.01% 1996
2024
Q4
$785K Sell
38,508
-1,392
-3% -$28.4K ﹤0.01% 1905
2024
Q3
$1.16M Buy
39,900
+24,767
+164% +$721K ﹤0.01% 1721
2024
Q2
$351K Buy
15,133
+390
+3% +$9.06K ﹤0.01% 2064
2024
Q1
$303K Sell
14,743
-605
-4% -$12.4K ﹤0.01% 2120
2023
Q4
$329K Buy
15,348
+3,267
+27% +$70.1K ﹤0.01% 2100
2023
Q3
$249K Buy
12,081
+630
+6% +$13K ﹤0.01% 2163
2023
Q2
$338K Sell
11,451
-267
-2% -$7.88K ﹤0.01% 2088
2023
Q1
$270K Sell
11,718
-1,538
-12% -$35.4K ﹤0.01% 2172
2022
Q4
$369K Buy
13,256
+1,631
+14% +$45.4K ﹤0.01% 2112
2022
Q3
$357K Buy
11,625
+742
+7% +$22.8K ﹤0.01% 2186
2022
Q2
$320K Hold
10,883
﹤0.01% 2214
2022
Q1
$259K Sell
10,883
-1,198
-10% -$28.5K ﹤0.01% 2345
2021
Q4
$539K Sell
12,081
-9,627
-44% -$430K ﹤0.01% 2111
2021
Q3
$1.1M Sell
21,708
-20,413
-48% -$1.03M ﹤0.01% 1820
2021
Q2
$3.3M Buy
42,121
+3,766
+10% +$295K ﹤0.01% 1482
2021
Q1
$2.19M Buy
38,355
+19,788
+107% +$1.13M ﹤0.01% 1627
2020
Q4
$1.56M Buy
18,567
+6,099
+49% +$511K ﹤0.01% 1596
2020
Q3
$447K Sell
12,468
-671
-5% -$24.1K ﹤0.01% 2004
2020
Q2
$318K Sell
13,139
-14,107
-52% -$341K ﹤0.01% 2158
2020
Q1
$478K Buy
27,246
+13,659
+101% +$240K ﹤0.01% 2108
2019
Q4
$237K Sell
13,587
-1,848
-12% -$32.2K ﹤0.01% 2269
2019
Q3
$236K Buy
+15,435
New +$236K ﹤0.01% 2164